Israel: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Israel

In 2022, the Israeli market for other medicaments for therapeutic or prophylactic uses increased by X% to $X, rising for the second year in a row after three years of decline. Over the period under review, consumption recorded resilient growth. Over the period under review, the market reached the peak level at $X in 2015; however, from 2016 to 2022, consumption failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Israel

In value terms, production of other medicaments for therapeutic or prophylactic uses declined sharply to $X in 2022 estimated in export price. Overall, production, however, recorded a dramatic contraction. The most prominent rate of growth was recorded in 2021 with an increase of X%. Production of peaked at $X in 2017; however, from 2018 to 2022, production remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Israel

In 2022, overseas shipments of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second consecutive year after three years of decline. Overall, exports, however, saw a drastic downturn. The exports peaked at X tons in 2017; however, from 2018 to 2022, the exports stood at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses soared to $X in 2022. Over the period under review, exports, however, recorded a noticeable downturn. The growth pace was the most rapid in 2021 with an increase of X%. The exports peaked at $X in 2017; however, from 2018 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

The UK (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Israel, with a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to the UK exceeded the volume sent to the second major destination, the United States (X tons), threefold.

From 2012 to 2022, the average annual rate of growth in terms of volume to the UK stood at X%.

In value terms, the UK ($X) remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Israel, comprising X% of total exports. The second position in the ranking was held by the United States ($X), with a X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value to the UK was relatively modest.

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, rising by X% against the previous year. In general, the export price posted a temperate increase. The pace of growth appeared the most rapid in 2021 an increase of X% against the previous year. Over the period under review, the average export prices reached the peak figure in 2022 and is expected to retain growth in years to come.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to the United States totaled $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the UK (X%).

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Israel

In 2022, imports of other medicaments for therapeutic or prophylactic uses into Israel contracted remarkably to X tons, waning by X% on 2021. In general, imports saw a deep reduction. The most prominent rate of growth was recorded in 2018 when imports increased by X%. As a result, imports attained the peak of X tons. From 2019 to 2022, the growth of imports of failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses dropped slightly to $X in 2022. Overall, imports showed a noticeable slump. The most prominent rate of growth was recorded in 2018 when imports increased by X%. Over the period under review, imports of attained the peak figure at $X in 2013; however, from 2014 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, Belgium (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to Israel, with a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Belgium exceeded the figures recorded by the second-largest supplier, the UK (X tons), threefold. China (X tons) ranked third in terms of total imports with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Belgium totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (X% per year) and China (X% per year).

In value terms, the largest other medicaments for therapeutic or prophylactic uses suppliers to Israel were Belgium ($X), the UK ($X) and Italy ($X), with a combined X% share of total imports. The United States, India, China and Canada lagged somewhat behind, together accounting for a further X%.

Canada, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, with an increase of X% against the previous year. Over the period under review, the import price recorded tangible growth. As a result, import price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was the UK ($X per ton), while the price for Canada ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :